In Phase II Trial, Vaccine Extends Glioblastoma Patients’ Survival
In Phase II Trial, Vaccine Extends Glioblastoma Patients’ Survival
A vaccine that turns the immune system against brain tumor cells bearing a genetic mutation that drives the most aggressive form of glioblastoma multiforme improved survival of patients in a phase II clinical trial, researchers at Duke University and The University of Texas MD Anderson Cancer Center reported today in the Journal of Clinical Oncology…
Read more on Medical News Today
Categories: Breast Cancer Tumor Tags: Extends, glioblastoma, Patients, Phase, Survival, Trial, vaccine
Scientists discover new signaling pathway to reduce tumour growth in glioblastoma multiforme
Scientists discover new signaling pathway to reduce tumour growth in glioblastoma multiforme
Malignant gliomas are the most common subtype of primary brain tumor – and one of the deadliest. Even as doctors make steady progress treating other types of solid tumor cancers, from breast to prostate, the most aggressive form of malignant glioma, called a glioblastoma multiforme or GBM, has steadfastly defied advances in neurosurgery, radiation therapy and various conventional or novel drugs …
Read more on News-Medical-Net
Categories: Breast Cancer Radiation Tags: Discover, glioblastoma, Growth, multiforme, pathway, Reduce, Scientists, signaling, tumour